Insider Trading (Form 4)
Xiaoyan Zhu, CFO of Park Ha Biological Technology Co., Ltd., received 112,500 shares of common stock on August 3, 2026.
Schedule 13G - Passive Investments
See all →Motovance Holdings Limited and Li Wang report a combined 9.7% beneficial ownership of Park Ha Biological Technology's Class A Ordinary Shares following warrant exercise.
Fusen Advertising Design Limited and Hao Meng report a combined 9.8% stake in Park Ha Biological Technology Co., Ltd. Class A Ordinary Shares.
Park Ha Biological Technology Co., Ltd. has filed a Schedule 13G detailing beneficial ownership changes and warrant exercisability.
SCHEDULE: Park Ha Biological Stakeholder Update
Nexera Technology and Jie Cao report a 9.1% stake in Park Ha Biological, including shares from upcoming warrant exercises.
Velociti Group Limited and Chunxin Xia report beneficial ownership of 9.8% of Park Ha Biological Technology's Class A Ordinary Shares, including exercisable warrants.
Rove Trading Co., Limited and Yingying Guo have jointly acquired a 9.8% stake in Park Ha Biological Technology Co., Ltd., as disclosed in a Schedule 13G filing.
Capital raise